IBS-C Drug Market, Global Outlook and Forecast 2022-2028
IBS?C is defined as belly pain (abdominal pain) associated with constipation. The symptoms of IBS?C are defined as long-lasting and keep coming back. Those suffering from IBS?C also have hard or lumpy stools at least 25% of the time, and loose or watery stools less than 25% of the time.
This report contains market size and forecasts of IBS-C Drug in global, including the following market information:
Global IBS-C Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global IBS-C Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five IBS-C Drug companies in 2021 (%)
The global IBS-C Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Amitiza Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of IBS-C Drug include Allergan, Takeda, Sucampo Pharmaceuticals and IM HealthScience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IBS-C Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IBS-C Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global IBS-C Drug Market Segment Percentages, by Type, 2021 (%)
Global IBS-C Drug Market Segment Percentages, by Distribution Channel, 2021 (%)
Global IBS-C Drug Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies IBS-C Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies IBS-C Drug revenues share in global market, 2021 (%)
Key companies IBS-C Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies IBS-C Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of IBS-C Drug in global, including the following market information:
Global IBS-C Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global IBS-C Drug Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five IBS-C Drug companies in 2021 (%)
The global IBS-C Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Amitiza Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of IBS-C Drug include Allergan, Takeda, Sucampo Pharmaceuticals and IM HealthScience, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IBS-C Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IBS-C Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global IBS-C Drug Market Segment Percentages, by Type, 2021 (%)
- Amitiza
- Lactulose
- Milk of Magnesia
- LINZESS (Linaclotide)
- Others
Global IBS-C Drug Market Segment Percentages, by Distribution Channel, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global IBS-C Drug Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies IBS-C Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies IBS-C Drug revenues share in global market, 2021 (%)
Key companies IBS-C Drug sales in global market, 2017-2022 (Estimated), (K Units)
Key companies IBS-C Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Allergan
- Takeda
- Sucampo Pharmaceuticals
- IM HealthScience
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 IBS-C Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Distribution Channel
1.3 Global IBS-C Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL IBS-C DRUG OVERALL MARKET SIZE
2.1 Global IBS-C Drug Market Size: 2021 VS 2028
2.2 Global IBS-C Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global IBS-C Drug Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top IBS-C Drug Players in Global Market
3.2 Top Global IBS-C Drug Companies Ranked by Revenue
3.3 Global IBS-C Drug Revenue by Companies
3.4 Global IBS-C Drug Sales by Companies
3.5 Global IBS-C Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 IBS-C Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers IBS-C Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 IBS-C Drug Players in Global Market
3.8.1 List of Global Tier 1 IBS-C Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 IBS-C Drug Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global IBS-C Drug Market Size Markets, 2021 & 2028
4.1.2 Amitiza
4.1.3 Lactulose
4.1.4 Milk of Magnesia
4.1.5 LINZESS (Linaclotide)
4.1.6 Others
4.2 By Type - Global IBS-C Drug Revenue & Forecasts
4.2.1 By Type - Global IBS-C Drug Revenue, 2017-2022
4.2.2 By Type - Global IBS-C Drug Revenue, 2023-2028
4.2.3 By Type - Global IBS-C Drug Revenue Market Share, 2017-2028
4.3 By Type - Global IBS-C Drug Sales & Forecasts
4.3.1 By Type - Global IBS-C Drug Sales, 2017-2022
4.3.2 By Type - Global IBS-C Drug Sales, 2023-2028
4.3.3 By Type - Global IBS-C Drug Sales Market Share, 2017-2028
4.4 By Type - Global IBS-C Drug Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY DISTRIBUTION CHANNEL
5.1 Overview
5.1.1 By Distribution Channel - Global IBS-C Drug Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Distribution Channel - Global IBS-C Drug Revenue & Forecasts
5.2.1 By Distribution Channel - Global IBS-C Drug Revenue, 2017-2022
5.2.2 By Distribution Channel - Global IBS-C Drug Revenue, 2023-2028
5.2.3 By Distribution Channel - Global IBS-C Drug Revenue Market Share, 2017-2028
5.3 By Distribution Channel - Global IBS-C Drug Sales & Forecasts
5.3.1 By Distribution Channel - Global IBS-C Drug Sales, 2017-2022
5.3.2 By Distribution Channel - Global IBS-C Drug Sales, 2023-2028
5.3.3 By Distribution Channel - Global IBS-C Drug Sales Market Share, 2017-2028
5.4 By Distribution Channel - Global IBS-C Drug Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global IBS-C Drug Market Size, 2021 & 2028
6.2 By Region - Global IBS-C Drug Revenue & Forecasts
6.2.1 By Region - Global IBS-C Drug Revenue, 2017-2022
6.2.2 By Region - Global IBS-C Drug Revenue, 2023-2028
6.2.3 By Region - Global IBS-C Drug Revenue Market Share, 2017-2028
6.3 By Region - Global IBS-C Drug Sales & Forecasts
6.3.1 By Region - Global IBS-C Drug Sales, 2017-2022
6.3.2 By Region - Global IBS-C Drug Sales, 2023-2028
6.3.3 By Region - Global IBS-C Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America IBS-C Drug Revenue, 2017-2028
6.4.2 By Country - North America IBS-C Drug Sales, 2017-2028
6.4.3 US IBS-C Drug Market Size, 2017-2028
6.4.4 Canada IBS-C Drug Market Size, 2017-2028
6.4.5 Mexico IBS-C Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe IBS-C Drug Revenue, 2017-2028
6.5.2 By Country - Europe IBS-C Drug Sales, 2017-2028
6.5.3 Germany IBS-C Drug Market Size, 2017-2028
6.5.4 France IBS-C Drug Market Size, 2017-2028
6.5.5 U.K. IBS-C Drug Market Size, 2017-2028
6.5.6 Italy IBS-C Drug Market Size, 2017-2028
6.5.7 Russia IBS-C Drug Market Size, 2017-2028
6.5.8 Nordic Countries IBS-C Drug Market Size, 2017-2028
6.5.9 Benelux IBS-C Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia IBS-C Drug Revenue, 2017-2028
6.6.2 By Region - Asia IBS-C Drug Sales, 2017-2028
6.6.3 China IBS-C Drug Market Size, 2017-2028
6.6.4 Japan IBS-C Drug Market Size, 2017-2028
6.6.5 South Korea IBS-C Drug Market Size, 2017-2028
6.6.6 Southeast Asia IBS-C Drug Market Size, 2017-2028
6.6.7 India IBS-C Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America IBS-C Drug Revenue, 2017-2028
6.7.2 By Country - South America IBS-C Drug Sales, 2017-2028
6.7.3 Brazil IBS-C Drug Market Size, 2017-2028
6.7.4 Argentina IBS-C Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa IBS-C Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa IBS-C Drug Sales, 2017-2028
6.8.3 Turkey IBS-C Drug Market Size, 2017-2028
6.8.4 Israel IBS-C Drug Market Size, 2017-2028
6.8.5 Saudi Arabia IBS-C Drug Market Size, 2017-2028
6.8.6 UAE IBS-C Drug Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Allergan
7.1.1 Allergan Corporate Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan IBS-C Drug Major Product Offerings
7.1.4 Allergan IBS-C Drug Sales and Revenue in Global (2017-2022)
7.1.5 Allergan Key News
7.2 Takeda
7.2.1 Takeda Corporate Summary
7.2.2 Takeda Business Overview
7.2.3 Takeda IBS-C Drug Major Product Offerings
7.2.4 Takeda IBS-C Drug Sales and Revenue in Global (2017-2022)
7.2.5 Takeda Key News
7.3 Sucampo Pharmaceuticals
7.3.1 Sucampo Pharmaceuticals Corporate Summary
7.3.2 Sucampo Pharmaceuticals Business Overview
7.3.3 Sucampo Pharmaceuticals IBS-C Drug Major Product Offerings
7.3.4 Sucampo Pharmaceuticals IBS-C Drug Sales and Revenue in Global (2017-2022)
7.3.5 Sucampo Pharmaceuticals Key News
7.4 IM HealthScience
7.4.1 IM HealthScience Corporate Summary
7.4.2 IM HealthScience Business Overview
7.4.3 IM HealthScience IBS-C Drug Major Product Offerings
7.4.4 IM HealthScience IBS-C Drug Sales and Revenue in Global (2017-2022)
7.4.5 IM HealthScience Key News
8 GLOBAL IBS-C DRUG PRODUCTION CAPACITY, ANALYSIS
8.1 Global IBS-C Drug Production Capacity, 2017-2028
8.2 IBS-C Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global IBS-C Drug Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 IBS-C DRUG SUPPLY CHAIN ANALYSIS
10.1 IBS-C Drug Industry Value Chain
10.2 IBS-C Drug Upstream Market
10.3 IBS-C Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 IBS-C Drug Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 IBS-C Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Distribution Channel
1.3 Global IBS-C Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL IBS-C DRUG OVERALL MARKET SIZE
2.1 Global IBS-C Drug Market Size: 2021 VS 2028
2.2 Global IBS-C Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global IBS-C Drug Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top IBS-C Drug Players in Global Market
3.2 Top Global IBS-C Drug Companies Ranked by Revenue
3.3 Global IBS-C Drug Revenue by Companies
3.4 Global IBS-C Drug Sales by Companies
3.5 Global IBS-C Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 IBS-C Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers IBS-C Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 IBS-C Drug Players in Global Market
3.8.1 List of Global Tier 1 IBS-C Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 IBS-C Drug Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global IBS-C Drug Market Size Markets, 2021 & 2028
4.1.2 Amitiza
4.1.3 Lactulose
4.1.4 Milk of Magnesia
4.1.5 LINZESS (Linaclotide)
4.1.6 Others
4.2 By Type - Global IBS-C Drug Revenue & Forecasts
4.2.1 By Type - Global IBS-C Drug Revenue, 2017-2022
4.2.2 By Type - Global IBS-C Drug Revenue, 2023-2028
4.2.3 By Type - Global IBS-C Drug Revenue Market Share, 2017-2028
4.3 By Type - Global IBS-C Drug Sales & Forecasts
4.3.1 By Type - Global IBS-C Drug Sales, 2017-2022
4.3.2 By Type - Global IBS-C Drug Sales, 2023-2028
4.3.3 By Type - Global IBS-C Drug Sales Market Share, 2017-2028
4.4 By Type - Global IBS-C Drug Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY DISTRIBUTION CHANNEL
5.1 Overview
5.1.1 By Distribution Channel - Global IBS-C Drug Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Distribution Channel - Global IBS-C Drug Revenue & Forecasts
5.2.1 By Distribution Channel - Global IBS-C Drug Revenue, 2017-2022
5.2.2 By Distribution Channel - Global IBS-C Drug Revenue, 2023-2028
5.2.3 By Distribution Channel - Global IBS-C Drug Revenue Market Share, 2017-2028
5.3 By Distribution Channel - Global IBS-C Drug Sales & Forecasts
5.3.1 By Distribution Channel - Global IBS-C Drug Sales, 2017-2022
5.3.2 By Distribution Channel - Global IBS-C Drug Sales, 2023-2028
5.3.3 By Distribution Channel - Global IBS-C Drug Sales Market Share, 2017-2028
5.4 By Distribution Channel - Global IBS-C Drug Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global IBS-C Drug Market Size, 2021 & 2028
6.2 By Region - Global IBS-C Drug Revenue & Forecasts
6.2.1 By Region - Global IBS-C Drug Revenue, 2017-2022
6.2.2 By Region - Global IBS-C Drug Revenue, 2023-2028
6.2.3 By Region - Global IBS-C Drug Revenue Market Share, 2017-2028
6.3 By Region - Global IBS-C Drug Sales & Forecasts
6.3.1 By Region - Global IBS-C Drug Sales, 2017-2022
6.3.2 By Region - Global IBS-C Drug Sales, 2023-2028
6.3.3 By Region - Global IBS-C Drug Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America IBS-C Drug Revenue, 2017-2028
6.4.2 By Country - North America IBS-C Drug Sales, 2017-2028
6.4.3 US IBS-C Drug Market Size, 2017-2028
6.4.4 Canada IBS-C Drug Market Size, 2017-2028
6.4.5 Mexico IBS-C Drug Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe IBS-C Drug Revenue, 2017-2028
6.5.2 By Country - Europe IBS-C Drug Sales, 2017-2028
6.5.3 Germany IBS-C Drug Market Size, 2017-2028
6.5.4 France IBS-C Drug Market Size, 2017-2028
6.5.5 U.K. IBS-C Drug Market Size, 2017-2028
6.5.6 Italy IBS-C Drug Market Size, 2017-2028
6.5.7 Russia IBS-C Drug Market Size, 2017-2028
6.5.8 Nordic Countries IBS-C Drug Market Size, 2017-2028
6.5.9 Benelux IBS-C Drug Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia IBS-C Drug Revenue, 2017-2028
6.6.2 By Region - Asia IBS-C Drug Sales, 2017-2028
6.6.3 China IBS-C Drug Market Size, 2017-2028
6.6.4 Japan IBS-C Drug Market Size, 2017-2028
6.6.5 South Korea IBS-C Drug Market Size, 2017-2028
6.6.6 Southeast Asia IBS-C Drug Market Size, 2017-2028
6.6.7 India IBS-C Drug Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America IBS-C Drug Revenue, 2017-2028
6.7.2 By Country - South America IBS-C Drug Sales, 2017-2028
6.7.3 Brazil IBS-C Drug Market Size, 2017-2028
6.7.4 Argentina IBS-C Drug Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa IBS-C Drug Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa IBS-C Drug Sales, 2017-2028
6.8.3 Turkey IBS-C Drug Market Size, 2017-2028
6.8.4 Israel IBS-C Drug Market Size, 2017-2028
6.8.5 Saudi Arabia IBS-C Drug Market Size, 2017-2028
6.8.6 UAE IBS-C Drug Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Allergan
7.1.1 Allergan Corporate Summary
7.1.2 Allergan Business Overview
7.1.3 Allergan IBS-C Drug Major Product Offerings
7.1.4 Allergan IBS-C Drug Sales and Revenue in Global (2017-2022)
7.1.5 Allergan Key News
7.2 Takeda
7.2.1 Takeda Corporate Summary
7.2.2 Takeda Business Overview
7.2.3 Takeda IBS-C Drug Major Product Offerings
7.2.4 Takeda IBS-C Drug Sales and Revenue in Global (2017-2022)
7.2.5 Takeda Key News
7.3 Sucampo Pharmaceuticals
7.3.1 Sucampo Pharmaceuticals Corporate Summary
7.3.2 Sucampo Pharmaceuticals Business Overview
7.3.3 Sucampo Pharmaceuticals IBS-C Drug Major Product Offerings
7.3.4 Sucampo Pharmaceuticals IBS-C Drug Sales and Revenue in Global (2017-2022)
7.3.5 Sucampo Pharmaceuticals Key News
7.4 IM HealthScience
7.4.1 IM HealthScience Corporate Summary
7.4.2 IM HealthScience Business Overview
7.4.3 IM HealthScience IBS-C Drug Major Product Offerings
7.4.4 IM HealthScience IBS-C Drug Sales and Revenue in Global (2017-2022)
7.4.5 IM HealthScience Key News
8 GLOBAL IBS-C DRUG PRODUCTION CAPACITY, ANALYSIS
8.1 Global IBS-C Drug Production Capacity, 2017-2028
8.2 IBS-C Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global IBS-C Drug Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 IBS-C DRUG SUPPLY CHAIN ANALYSIS
10.1 IBS-C Drug Industry Value Chain
10.2 IBS-C Drug Upstream Market
10.3 IBS-C Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 IBS-C Drug Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of IBS-C Drug in Global Market
Table 2. Top IBS-C Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global IBS-C Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global IBS-C Drug Revenue Share by Companies, 2017-2022
Table 5. Global IBS-C Drug Sales by Companies, (K Units), 2017-2022
Table 6. Global IBS-C Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers IBS-C Drug Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers IBS-C Drug Product Type
Table 9. List of Global Tier 1 IBS-C Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IBS-C Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global IBS-C Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global IBS-C Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global IBS-C Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global IBS-C Drug Sales (K Units), 2017-2022
Table 15. By Type - Global IBS-C Drug Sales (K Units), 2023-2028
Table 16. By Distribution Channel – Global IBS-C Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Distribution Channel - Global IBS-C Drug Revenue (US$, Mn), 2017-2022
Table 18. By Distribution Channel - Global IBS-C Drug Revenue (US$, Mn), 2023-2028
Table 19. By Distribution Channel - Global IBS-C Drug Sales (K Units), 2017-2022
Table 20. By Distribution Channel - Global IBS-C Drug Sales (K Units), 2023-2028
Table 21. By Region – Global IBS-C Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global IBS-C Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global IBS-C Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global IBS-C Drug Sales (K Units), 2017-2022
Table 25. By Region - Global IBS-C Drug Sales (K Units), 2023-2028
Table 26. By Country - North America IBS-C Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America IBS-C Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America IBS-C Drug Sales, (K Units), 2017-2022
Table 29. By Country - North America IBS-C Drug Sales, (K Units), 2023-2028
Table 30. By Country - Europe IBS-C Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe IBS-C Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe IBS-C Drug Sales, (K Units), 2017-2022
Table 33. By Country - Europe IBS-C Drug Sales, (K Units), 2023-2028
Table 34. By Region - Asia IBS-C Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia IBS-C Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia IBS-C Drug Sales, (K Units), 2017-2022
Table 37. By Region - Asia IBS-C Drug Sales, (K Units), 2023-2028
Table 38. By Country - South America IBS-C Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America IBS-C Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America IBS-C Drug Sales, (K Units), 2017-2022
Table 41. By Country - South America IBS-C Drug Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa IBS-C Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa IBS-C Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa IBS-C Drug Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa IBS-C Drug Sales, (K Units), 2023-2028
Table 46. Allergan Corporate Summary
Table 47. Allergan IBS-C Drug Product Offerings
Table 48. Allergan IBS-C Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Takeda Corporate Summary
Table 50. Takeda IBS-C Drug Product Offerings
Table 51. Takeda IBS-C Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Sucampo Pharmaceuticals Corporate Summary
Table 53. Sucampo Pharmaceuticals IBS-C Drug Product Offerings
Table 54. Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. IM HealthScience Corporate Summary
Table 56. IM HealthScience IBS-C Drug Product Offerings
Table 57. IM HealthScience IBS-C Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. IBS-C Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 59. Global IBS-C Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global IBS-C Drug Production by Region, 2017-2022 (K Units)
Table 61. Global IBS-C Drug Production by Region, 2023-2028 (K Units)
Table 62. IBS-C Drug Market Opportunities & Trends in Global Market
Table 63. IBS-C Drug Market Drivers in Global Market
Table 64. IBS-C Drug Market Restraints in Global Market
Table 65. IBS-C Drug Raw Materials
Table 66. IBS-C Drug Raw Materials Suppliers in Global Market
Table 67. Typical IBS-C Drug Downstream
Table 68. IBS-C Drug Downstream Clients in Global Market
Table 69. IBS-C Drug Distributors and Sales Agents in Global Market
Table 1. Key Players of IBS-C Drug in Global Market
Table 2. Top IBS-C Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global IBS-C Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global IBS-C Drug Revenue Share by Companies, 2017-2022
Table 5. Global IBS-C Drug Sales by Companies, (K Units), 2017-2022
Table 6. Global IBS-C Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers IBS-C Drug Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers IBS-C Drug Product Type
Table 9. List of Global Tier 1 IBS-C Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IBS-C Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global IBS-C Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global IBS-C Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global IBS-C Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global IBS-C Drug Sales (K Units), 2017-2022
Table 15. By Type - Global IBS-C Drug Sales (K Units), 2023-2028
Table 16. By Distribution Channel – Global IBS-C Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Distribution Channel - Global IBS-C Drug Revenue (US$, Mn), 2017-2022
Table 18. By Distribution Channel - Global IBS-C Drug Revenue (US$, Mn), 2023-2028
Table 19. By Distribution Channel - Global IBS-C Drug Sales (K Units), 2017-2022
Table 20. By Distribution Channel - Global IBS-C Drug Sales (K Units), 2023-2028
Table 21. By Region – Global IBS-C Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global IBS-C Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global IBS-C Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global IBS-C Drug Sales (K Units), 2017-2022
Table 25. By Region - Global IBS-C Drug Sales (K Units), 2023-2028
Table 26. By Country - North America IBS-C Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America IBS-C Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America IBS-C Drug Sales, (K Units), 2017-2022
Table 29. By Country - North America IBS-C Drug Sales, (K Units), 2023-2028
Table 30. By Country - Europe IBS-C Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe IBS-C Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe IBS-C Drug Sales, (K Units), 2017-2022
Table 33. By Country - Europe IBS-C Drug Sales, (K Units), 2023-2028
Table 34. By Region - Asia IBS-C Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia IBS-C Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia IBS-C Drug Sales, (K Units), 2017-2022
Table 37. By Region - Asia IBS-C Drug Sales, (K Units), 2023-2028
Table 38. By Country - South America IBS-C Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America IBS-C Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America IBS-C Drug Sales, (K Units), 2017-2022
Table 41. By Country - South America IBS-C Drug Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa IBS-C Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa IBS-C Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa IBS-C Drug Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa IBS-C Drug Sales, (K Units), 2023-2028
Table 46. Allergan Corporate Summary
Table 47. Allergan IBS-C Drug Product Offerings
Table 48. Allergan IBS-C Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Takeda Corporate Summary
Table 50. Takeda IBS-C Drug Product Offerings
Table 51. Takeda IBS-C Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Sucampo Pharmaceuticals Corporate Summary
Table 53. Sucampo Pharmaceuticals IBS-C Drug Product Offerings
Table 54. Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. IM HealthScience Corporate Summary
Table 56. IM HealthScience IBS-C Drug Product Offerings
Table 57. IM HealthScience IBS-C Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. IBS-C Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 59. Global IBS-C Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global IBS-C Drug Production by Region, 2017-2022 (K Units)
Table 61. Global IBS-C Drug Production by Region, 2023-2028 (K Units)
Table 62. IBS-C Drug Market Opportunities & Trends in Global Market
Table 63. IBS-C Drug Market Drivers in Global Market
Table 64. IBS-C Drug Market Restraints in Global Market
Table 65. IBS-C Drug Raw Materials
Table 66. IBS-C Drug Raw Materials Suppliers in Global Market
Table 67. Typical IBS-C Drug Downstream
Table 68. IBS-C Drug Downstream Clients in Global Market
Table 69. IBS-C Drug Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. IBS-C Drug Segment by Type
Figure 2. IBS-C Drug Segment by Distribution Channel
Figure 3. Global IBS-C Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global IBS-C Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global IBS-C Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. IBS-C Drug Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by IBS-C Drug Revenue in 2021
Figure 9. By Type - Global IBS-C Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global IBS-C Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global IBS-C Drug Price (USD/Unit), 2017-2028
Figure 12. By Distribution Channel - Global IBS-C Drug Sales Market Share, 2017-2028
Figure 13. By Distribution Channel - Global IBS-C Drug Revenue Market Share, 2017-2028
Figure 14. By Distribution Channel - Global IBS-C Drug Price (USD/Unit), 2017-2028
Figure 15. By Region - Global IBS-C Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global IBS-C Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America IBS-C Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America IBS-C Drug Sales Market Share, 2017-2028
Figure 19. US IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe IBS-C Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe IBS-C Drug Sales Market Share, 2017-2028
Figure 24. Germany IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia IBS-C Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia IBS-C Drug Sales Market Share, 2017-2028
Figure 33. China IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America IBS-C Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America IBS-C Drug Sales Market Share, 2017-2028
Figure 40. Brazil IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa IBS-C Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa IBS-C Drug Sales Market Share, 2017-2028
Figure 44. Turkey IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global IBS-C Drug Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production IBS-C Drug by Region, 2021 VS 2028
Figure 50. IBS-C Drug Industry Value Chain
Figure 51. Marketing Channels
Figure 1. IBS-C Drug Segment by Type
Figure 2. IBS-C Drug Segment by Distribution Channel
Figure 3. Global IBS-C Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global IBS-C Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global IBS-C Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. IBS-C Drug Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by IBS-C Drug Revenue in 2021
Figure 9. By Type - Global IBS-C Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global IBS-C Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global IBS-C Drug Price (USD/Unit), 2017-2028
Figure 12. By Distribution Channel - Global IBS-C Drug Sales Market Share, 2017-2028
Figure 13. By Distribution Channel - Global IBS-C Drug Revenue Market Share, 2017-2028
Figure 14. By Distribution Channel - Global IBS-C Drug Price (USD/Unit), 2017-2028
Figure 15. By Region - Global IBS-C Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global IBS-C Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America IBS-C Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America IBS-C Drug Sales Market Share, 2017-2028
Figure 19. US IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe IBS-C Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe IBS-C Drug Sales Market Share, 2017-2028
Figure 24. Germany IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia IBS-C Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia IBS-C Drug Sales Market Share, 2017-2028
Figure 33. China IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America IBS-C Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America IBS-C Drug Sales Market Share, 2017-2028
Figure 40. Brazil IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa IBS-C Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa IBS-C Drug Sales Market Share, 2017-2028
Figure 44. Turkey IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE IBS-C Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global IBS-C Drug Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production IBS-C Drug by Region, 2021 VS 2028
Figure 50. IBS-C Drug Industry Value Chain
Figure 51. Marketing Channels
